M
Mark E. Gurney
Researcher at deCODE genetics
Publications - 147
Citations - 22658
Mark E. Gurney is an academic researcher from deCODE genetics. The author has contributed to research in topics: Amyotrophic lateral sclerosis & Motor neuron. The author has an hindex of 55, co-authored 140 publications receiving 21917 citations. Previous affiliations of Mark E. Gurney include Loyola University Medical Center & Northwestern University.
Papers
More filters
Journal ArticleDOI
Immunohistochemical study on the distribution of Bcl-2 and Bax in the central nervous system of the transgenic mice expressing a human Cu/Zn SOD mutation.
Chung-Min Shin,Yoon Hee Chung,Myeung Ju Kim,Dong Hoon Shin,Dong Hoon Shin,Yong Sik Kim,Mark E. Gurney,Kwang Woo Lee,Choong Ik Cha +8 more
TL;DR: The distribution of Bcl-2 and Bax is demonstrated in detail using immunohistochemical methods through the central nervous system of the transgenic mice, for the first time.
Patent
Methods of preventing or treating recurrence of myocardial infarction
TL;DR: In this paper, the linkage of myocardial infarction (MI) with a locus on chromosome 12q23 is disclosed, and the LTA4H gene within this locus is shown by association analysis to be a susceptibility gene for MI.
Patent
Hiv-related antigens and antibodies
Mark E. Gurney,David D. Ho +1 more
TL;DR: In this article, novel immunochemical reagents including non-neurotoxic peptides having amino acid sequence homology to loop sequences within residues 230 to 300 of the gp 120 glycoprotein of HIV-IIIB and antibodies thereto are capable of in vitro inhibition of HIV infectivity.
Journal ArticleDOI
Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing
TL;DR: The profound activating and expansion stimulus provided by feeder cells is integral to current applications of clinical-scale genome engineering approaches in donor-derived, primary NK cells, and the complex interactions that exist between feeders and both viral and emerging non-viral genome editing technologies in NK cell engineering are explored.
Patent
Susceptibility gene for myocardial infarction; methods of treatment
TL;DR: Linkage of myocardial infarction (MI) and a locus on chromosome 13q12 is disclosed in this article, where the FLAP gene within this locus is shown by genetic association analysis to be a susceptibility gene for MI.